Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Natural killer T cell and pathophysiology of asthma

  • Jang, Gwang Cheon (Department of Pediatrics, NHIC Ilsan Hospital)
  • Received : 2010.02.01
  • Accepted : 2009.02.05
  • Published : 2010.02.15
Download PDF
⟨ Previous Next ⟩

Abstract

Natural killer T (NKT) cell is a special type of T lymphocytes that has both receptor of natural killer (NK) cell (NK1.1, CD161c) and T cell (TCR) and express a conserved or invariant T cell receptor called $V{\alpha}14J{\alpha}18$ in mice or Va24 in humans. Invariant NKT (iNKT) cell recognizes lipid antigen presented by CD1d molecules. Marine-sponge-derived glycolipid, ${\alpha}-galactosylceremide$ (${\alpha}-GalCer$), binds CD1d at the cell surface of antigen-presenting cells and is presented to iNKT cells. Within hours, iNKT cells become activated and start to secrete Interleukin-4 and $interferon-{\gamma}$. NKT cell prevents autoimmune diseases, such as type 1 diabetes, experimental allergic encephalomyelitis, systemic lupus erythematous, inflammatory colitis, and Graves' thyroiditis, by activation with ${\alpha}-GalCer$. In addition, NKT cell is associated with infectious diseases by mycobacteria, leshmania, and virus. Moreover NKT cell is associated with asthma, especially CD4+ iNKT cells. In this review, I will discuss the characteristics of NKT cell and the association with inflammatory diseases, especially asthma.

Keywords

References

  1. Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002.;3:715-20 https://doi.org/10.1038/ni0802-715
  2. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304 https://doi.org/10.1056/NEJM199201303260504
  3. Meyer EH, DeKruyff RH, Umetsu DT. T cells and NKT cells in the pathogenesis of asthma. Annu Rev Med 2008;59:281-92 https://doi.org/10.1146/annurev.med.59.061506.154139
  4. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582-8 https://doi.org/10.1038/nm851
  5. Kim EY, Battale JT, Patel AC, You Y, Agapov E, Grayson MH, et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 2008;14:633-40 https://doi.org/10.1038/nm1770
  6. Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlström J, Kronenberg M, .et al. CD4+ invariant T-cell-receptor plus natural killer T cells in bronchial asthma. N Engl J Med 2006;354:1117-9 https://doi.org/10.1056/NEJMoa053614
  7. Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, Hachem P, et al. Cutting edge: invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol 2003;171:1637-1
  8. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007;25:297-336 https://doi.org/10.1146/annurev.immunol.25.022106.141711
  9. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17 https://doi.org/10.1084/jem.20071507
  10. Kaer LV. $\alpha$-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat Rev Immunol 2005;5:31-42 https://doi.org/10.1038/nri1531
  11. Budd RC, Miescher GC, Howe RC, Lees RK, Bron C, Mac- Donald HR. Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes. J Exp Med 1987;166:577-82 https://doi.org/10.1084/jem.166.2.577
  12. Sykes M, Hoyles KA, Romick ML, Sachs DH. In vitro and in vivo analysis of bone marrow-derived CD3+, CD4-, CD8-, NK1.1+ cell lines. Cell Immunol 1990;129:478-93 https://doi.org/10.1016/0008-8749(90)90222-D
  13. Zlotnik A, Godfrey DI, Fischer M, Suda T. Cytokine production by mature and immature CD4-CD8- T cells. Alpha beta-T cell receptor+ CD4-CD8- T cells produce IL-4. J Immunol 1992;149:1211-5
  14. Arase H, Arase N, Nakagawa K, Good RA, Ono$\'{e}$ K. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion. Eur J Immunol 1993;23:307-10 https://doi.org/10.1002/eji.1830230151
  15. Yoshimoto T, Paul WE. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994;179:1285-95 https://doi.org/10.1084/jem.179.4.1285
  16. Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M. Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. Int Immunol 1995;7:1157-61 https://doi.org/10.1093/intimm/7.7.1157
  17. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1- specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997;15:535-62 https://doi.org/10.1146/annurev.immunol.15.1.535
  18. Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 1995;7:529-34
  19. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. NKT cells: What's in a name? Nat Rev Immunol 2004;4:231-7 https://doi.org/10.1038/nri1309
  20. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002;2:557-68
  21. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007;7:505-18 https://doi.org/10.1038/nri2116
  22. Zajonc DM, Kronenberg M. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells. Immunol Rev 2009;230:188-200 https://doi.org/10.1111/j.1600-065X.2009.00802.x
  23. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumor immunity. Nat Rev Immunol 2003;3:211-22 https://doi.org/10.1038/nri1028
  24. Hwang SJ, Kim S, Park WS, Chung DH. IL-4-secreting NKT cells prevent hypersensitivity pneumonitis by suppressing IFNgamma- producing neutrophils. J Immunol 2006;177:5258-68
  25. Korosec P, Osolnik K, Kern I, Silar M, Mohorcic K, Kosnik M. Expansion of pulmonary CD8+CD56+ natural killer Tcells in hypersensitivity pneumonitis. Chest 2007;132:1291-7 https://doi.org/10.1378/chest.07-0128
  26. Lind SM, Kuylenstierna C, Moll M, Jordo ED, Winqvist O, Lundberg L, et al. IL-18 skews the invariant NKT-cell population via autoreactive activation in atopic eczema. Eur J Immunol 2009;39:2293-301 https://doi.org/10.1002/eji.200839195
  27. Simon D, Kozlowski E, Simon H. Natural killer T cells expressing $ INF-\gamma$ and IL-4 in lesional skin of atopic eczema. Allergy 2009;64:1681-4 https://doi.org/10.1111/j.1398-9995.2009.02097.x
  28. Kim JH, Kim HY, Kim S, Chung JH, Park WS, Chung DH. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am J Pathol 2005;167:1231-41
  29. Holtzman MJ, Byers DE, Benoit LA, Battaile JT, You Y, Agapov E, et al. Immune pathways for translating viral infection into chronic airway disease. Adv Immunol 2009;102:245-76 https://doi.org/10.1016/S0065-2776(09)01205-X
  30. Koh YI, Kim HY, Meyer EH, Pichavant M, Akbari O, Yasumi T, et al. Activation of nonclassical CD1d-restircted NKT cells induces airway hyperreactivity in $\beta$2-microglobulin-deficient mice. J Immunol 2008;181:4560-9
  31. Kim HY, Pichavant M, Matangkasombut P, Koh YI, Savage PB, DeKruyff RH, et al. The development of airway hyperreactivity in T-bet-deficient mice requires CD1d-restricted NKT cells. J Immunol 2009;182:3252-61 https://doi.org/10.4049/jimmunol.0803339
  32. Finkelman FD, Yang M, Orekhova T, Clyne E, Bernstein J, Whitekus M, et al. Diesel exhaust particles suppress in vivo $INF-\gamma$ production by inhibiting cytokine effects on NK and NKT cells. J Immunol 2004;172:3808-13
  33. Terashima A, Watarai H, Inoue S, Sekine E, Nakagawa R, Hase K, et al. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 2008;205:2727-33 https://doi.org/10.1084/jem.20080698
  34. Stock P, Lombardi V, Kohlrautz V, Akbari O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J Immunol 2009;182:5116-22 https://doi.org/10.4049/jimmunol.0804213
  35. Akbari O, Stock P, Singh AK, Lombardil V, Lee WL, Freeman GJ, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol 2010;3:81-91 https://doi.org/10.1038/mi.2009.112
  36. Thomas SY, Banerji A, Medoff BD, Lilly CM, Luster AD. Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway. J Immunol 2007;179:1901-12
  37. Matangkasombut P, Marigowda G, Ervine A, Idris L, Pichavant M, Kim HY, et al. Natural killer T cells in the lungs of patients with asthma. J Allergy Clin Immunol 2009;123:1181-5 https://doi.org/10.1016/j.jaci.2009.02.013
  38. Koh YI, Shim JU, Wi JO, Han ER, Jin NC, Oh SH, et al. Inverse association of peripheral blood CD4(+) invariant natural killer T cells with atopy in human asthma. Hum Immunol 2010;71:186-91 https://doi.org/10.1016/j.humimm.2009.10.011
  39. Umetsu DT, DeKruyff RH. A role for natural killer T cells in asthma. Nat Rev Immunol 2006;6:953-8 https://doi.org/10.1038/nri1968